Boosting D-Lactic Acid Production Through UV Irradiation Advances
In a groundbreaking advancement with far-reaching implications for sustainable chemical production, researchers at Osaka Metropolitan University have engineered a novel yeast strain capable of significantly enhancing the biosynthesis of D-lactic acid directly from methanol. This achievement not only opens new pathways for bio-based manufacturing but also addresses pressing global concerns surrounding the depletion of fossil […]

In a groundbreaking advancement with far-reaching implications for sustainable chemical production, researchers at Osaka Metropolitan University have engineered a novel yeast strain capable of significantly enhancing the biosynthesis of D-lactic acid directly from methanol. This achievement not only opens new pathways for bio-based manufacturing but also addresses pressing global concerns surrounding the depletion of fossil resources and escalating petroleum costs.
D-lactic acid, a chiral molecule integral to multiple industrial applications, is a crucial precursor in the manufacture of biodegradable plastics and pharmaceutical compounds. Conventionally, its production relies on sugar feedstocks, which compete with food resources and are subject to volatile pricing and supply issues. Methanol, a single-carbon compound that can be synthesized from abundant natural gas or even captured carbon dioxide, represents an attractive alternative raw material. However, efficient biological conversion of methanol into high-value products has long posed a formidable challenge due to metabolic and genetic limitations of microbial hosts.
The research team, headed by Associate Professor Ryosuke Yamada, has focused their efforts on Komagataella phaffii, a methylotrophic yeast species previously recognized for its utility in heterologous protein production. By exploiting the organism’s unique metabolic pathways, which naturally assimilate methanol as a carbon source, they aimed to redirect the carbon flux toward enhanced D-lactic acid synthesis. This required the innovative integration of metabolic engineering strategies with classical mutagenesis techniques.
.adsslot_nRx9hTsUA3{ width:728px !important; height:90px !important; }
@media (max-width:1199px) { .adsslot_nRx9hTsUA3{ width:468px !important; height:60px !important; } }
@media (max-width:767px) { .adsslot_nRx9hTsUA3{ width:320px !important; height:50px !important; } }
ADVERTISEMENT
Central to their approach was the application of ultraviolet (UV) irradiation to the K. phaffii genome, a method that induces random genetic mutations by causing DNA damage. Although UV mutagenesis is an age-old tool, its combination with modern genomic sequencing technologies ushered in precision previously unattainable. By irradiating yeast cultures and subsequently screening for improved D-lactic acid yield, the team isolated a superior mutant strain, designated DLac_Mut2_221, which exhibited approximately 1.5-fold increase in production efficiency compared to its parental counterpart.
This enhanced phenotype was subjected to rigorous genetic analysis utilizing next-generation sequencing platforms. The comprehensive genotypic profiling revealed mutations in several key genes involved in central carbon metabolism, redox balancing, and pyruvate flux regulation—elements crucial for optimizing D-lactic acid biosynthesis. Insights gleaned from these mutations provide a clearer mechanistic understanding of metabolic bottlenecks and pave the way for rational strain design efforts to further amplify production yields.
Beyond the immediate improvement in D-lactic acid output, this research exemplifies a scalable and environmentally sustainable concept: leveraging engineered methylotrophic microbes for chemical synthesis from single-carbon substrates. Such bioprocesses stand to revolutionize the chemical industry by offering lower energy consumption, reduced greenhouse gas emissions, and decreased reliance on petrochemical sources.
Moreover, the use of next-generation sequencing in dissecting mutagenesis outcomes allows rapid iteration cycles in strain development, merging classical and contemporary biotechnology methods. This integrative approach accelerates the timeline from strain construction to commercial viability, a critical factor in competitive biomanufacturing sectors.
Professor Yamada emphasizes the broader horizon offered by this technology platform. While current efforts focus on D-lactic acid, the engineered K. phaffii chassis can be further tailored to synthesize diverse intermediates and specialty chemicals, laying a foundation for an entire bioeconomy anchored in methanol-based feedstocks. This could address supply constraints and environmental impacts associated with traditional fermentations reliant on sugars or starches.
The implications of this research resonate with global sustainability goals, as the gradual shift from fossil-derived to bio-derived chemicals could curtail carbon footprints while fostering circular resource utilization. Utilizing methanol, which can be sourced from renewable biomass gasification or direct CO2 hydrogenation, aligns bioproduction processes with emerging carbon recycling paradigms.
This study’s success also reflects the strategic interplay between genetic engineering, process optimization, and systems biology. Future efforts will likely encompass pathway elucidation, enzyme engineering, and advanced fermentation techniques such as continuous bioprocessing to maximize productivity and operational robustness.
In light of the COVID-19 pandemic’s impact on supply chain reliability and increasing geopolitical tensions affecting energy markets, decentralized and resilient bio-manufacturing routes gain even greater significance. Yeast strains like DLac_Mut2_221 represent a vital step toward that vision, facilitating the synthesis of key industrial compounds under bio-safe, cost-effective conditions.
Moving forward, the team at Osaka Metropolitan University plans to harness computational modeling and machine learning to predict beneficial mutations, further refining the metabolic networks of K. phaffii. Combining this with directed evolution and synthetic biology tools will expedite the creation of microbial strains tailored to diverse industrial demands.
This innovation underscores the untapped potential residing within microbial methylotrophs, whose natural ability to metabolize simple carbon compounds can be harnessed and enhanced to meet the urgent global need for sustainable chemical production. As the bioeconomy evolves, engineered yeasts like these could redefine standard production methods, markedly reducing environmental footprints and catalyzing a transition to greener manufacturing paradigms.
Overall, the research heralds a new era in industrial biotechnology: one where single-carbon substrates such as methanol feed streamlined microbial cell factories to yield high-value biochemicals. By blending classical mutagenesis with state-of-the-art genomics and metabolic engineering, this study charts a blueprint for future innovation in bio-based chemical manufacturing.
Subject of Research: Not applicable
Article Title: Improvement of D-lactic acid production from methanol by metabolically engineered Komagataella phaffii via ultra-violet mutagenesis
News Publication Date: 17-May-2025
Web References: http://dx.doi.org/10.1016/j.mec.2025.e00262
Image Credits: Osaka Metropolitan University
Keywords: D-lactic acid, methanol bioconversion, Komagataella phaffii, UV mutagenesis, metabolic engineering, methylotrophic yeast, bio-based production, next-generation sequencing, sustainable chemistry, bioplastics, synthetic biology
Tags: alternatives to sugar feedstocksbiodegradable plastics manufacturingcarbon capture and utilization technologiesD-lactic acid productionengineered yeast strains for bioprocessingKomagataella phaffii applicationsmetabolic engineering in yeastmethanol as a raw materialpharmaceutical applications of D-lactic acidrenewable resources for chemical synthesissustainable chemical production advancementsUV irradiation impact on biosynthesis
What's Your Reaction?






